Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
a factor of increased importance for consumers on a weight management journey and those coming off of GLP-1 medications
See detailed requirements below
The difference is stark
Timothy Garvey served as principal investigator for the landmark REDEFINE 1 trial published in The New England Journal of Medicine in 2025, which established the GLP1-cagrilintide combination as producing the highest pharmaceutical weight loss observed to date
Business Type Exporter, Manufacturer, Supplier, Trading Company Employee Count 15 Establishment 2019 Working Days To GST NO 09ABBFR0665G1Z7 Payment Mode Online Payments (NEFT/RTGS/IMPS) Certification ISO 9001:2008 Related Products Explore Related Categories More Products From This Seller Seller Details GST - 09ABBFR0665G1Z7 Mathura, Uttar Pradesh Partner Mr
Tirzepatide 30mg 30mg 99.86% TIRZ30-2603-01 Tirzepatide 15mg 15mg 99.66% TIRZ15-2601-01 Price & value per mg, research-grade Tirzepatide (Australia) Per-mg value is calculated from current vial pricing
